{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=5%25+Dextrose+%28Placebo%29&page=2", "query": { "intervention": "5% Dextrose (Placebo)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 213, "total_pages": 22, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=5%25+Dextrose+%28Placebo%29&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=5%25+Dextrose+%28Placebo%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T12:08:05.947Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04986072", "title": "Sodium Nitroprusside in Early Course Schizophrenia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder" ], "interventions": [ { "name": "Sodium Nitroprusside", "type": "DRUG" }, { "name": "5% Dextrose solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 1, "start_date": "2022-03-14", "completion_date": "2024-07-01", "has_results": true, "last_update_posted_date": "2025-12-30", "last_synced_at": "2026-10-08T12:08:05.947Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04986072" }, { "nct_id": "NCT00762736", "title": "Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus" ], "interventions": [ { "name": "Pioglitazone and azilsartan", "type": "DRUG" }, { "name": "Pioglitazone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 704, "start_date": "2004-07", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2012-02-28", "last_synced_at": "2026-10-08T12:08:05.947Z", "location_count": 64, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Sierra Vista, Arizona + 61 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Sierra Vista", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00762736" }, { "nct_id": "NCT00410410", "title": "A Study of Abatacept in Patients With Active Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "abatacept (ABA)", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "abatacept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 591, "start_date": "2006-12", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2015-03-24", "last_synced_at": "2026-10-08T12:08:05.947Z", "location_count": 50, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Los Angeles, California + 43 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00410410" }, { "nct_id": "NCT03478215", "title": "Mesenchymal Stromal Cells in Living Donor Kidney Transplantation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Renal Transplantation", "Mesenchymal Stem Cells" ], "interventions": [ { "name": "Mesenchymal Stromal Stem Cells (MSCs) Infusion", "type": "BIOLOGICAL" }, { "name": "Normal Saline (Placebo) Infusion", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "The Methodist Hospital Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 24, "start_date": "2016-12", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2025-03-14", "last_synced_at": "2026-10-08T12:08:05.947Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03478215" }, { "nct_id": "NCT02127125", "title": "Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Insulin Sensitivity" ], "interventions": [ { "name": "Maltodextrin", "type": "DRUG" }, { "name": "Synbiotic", "type": "DRUG" }, { "name": "Sevelamer", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center at San Antonio", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 69, "start_date": "2014-04-10", "completion_date": "2018-09-10", "has_results": true, "last_update_posted_date": "2020-09-11", "last_synced_at": "2026-10-08T12:08:05.947Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02127125" }, { "nct_id": "NCT02556918", "title": "Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hyperglycemia" ], "interventions": [ { "name": "Sitagliptin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Regular Human Insulin", "type": "DRUG" }, { "name": "Insulin glargine", "type": "DRUG" }, { "name": "Supplemental insulin (Insulin lispro)", "type": "DRUG" }, { "name": "Supplemental insulin (Insulin aspart)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 202, "start_date": "2016-01", "completion_date": "2018-11-06", "has_results": true, "last_update_posted_date": "2019-12-23", "last_synced_at": "2026-10-08T12:08:05.947Z", "location_count": 3, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02556918" }, { "nct_id": "NCT06611111", "title": "Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Post-Treatment Lyme Disease" ], "interventions": [ { "name": "Ceftriaxone (Rocephin®)", "type": "DRUG" }, { "name": "Dextrose 5% (D5W)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "State University of New York - Upstate Medical University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 44, "start_date": "2025-02-03", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-03-19", "last_synced_at": "2026-10-08T12:08:05.947Z", "location_count": 1, "location_summary": "East Syracuse, New York", "locations": [ { "city": "East Syracuse", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06611111" }, { "nct_id": "NCT01969409", "title": "Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ambulatory IPF" ], "interventions": [ { "name": "Rituximab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 58, "start_date": "2014-01", "completion_date": "2020-11-30", "has_results": true, "last_update_posted_date": "2024-08-21", "last_synced_at": "2026-10-08T12:08:05.947Z", "location_count": 7, "location_summary": "Birmingham, Alabama • Boston, Massachusetts • Minneapolis, Minnesota + 4 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Danville", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01969409" }, { "nct_id": "NCT04475198", "title": "Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute, Post-operative Pain" ], "interventions": [ { "name": "ST-2427", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SiteOne Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 24, "start_date": "2021-03-04", "completion_date": "2021-08-18", "has_results": true, "last_update_posted_date": "2023-08-03", "last_synced_at": "2026-10-08T12:08:05.947Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04475198" }, { "nct_id": "NCT00872599", "title": "The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "fenofibrate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 75, "start_date": "2009-09", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2013-06-28", "last_synced_at": "2026-10-08T12:08:05.947Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00872599" } ] }